Similar articles

• The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes.

  Braatvedt GD, Bagg W, Gamble G, Davidson J, Reid IR. Braatvedt GD, et al. Bone. 2004 Sep;35(3):766-70. doi: 10.1016/j.bone.2004.05.001. Bone. 2004. PMID: 15336614 Clinical Trial.
• Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

  Berthold HK, Unverdorben S, Zittermann A, Degenhardt R, Baumeister B, Unverdorben M, Krone W, Vetter H, Gouni-Berthold I. Berthold HK, et al. Osteoporos Int. 2004 Jun;15(6):459-67. doi: 10.1007/s00198-004-1598-1. Epub 2004 Feb 14. Osteoporos Int. 2004. PMID: 15205717 Clinical Trial.
• [Changes in bone mass with atorvastatin. BM AND AT study].

  Valle MB, Amez JM, Molinero ÁV, Gallego VA, Torres MS. Valle MB, et al. Aten Primaria. 2011 Mar;43(3):160-1. doi: 10.1016/j.aprim.2010.01.026. Epub 2010 May 24. Aten Primaria. 2011. PMID: 20494488 Free PMC article. Spanish. No abstract available.
• Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats.

  Chang B, Yang J, Li H, Lu S, Chen L, Fang P. Chang B, et al. Pharmazie. 2011 Jul;66(7):535-7. Pharmazie. 2011. PMID: 21812330
• [Clopidogrel and statins or once more on the danger of direct transfer of results of experimental studies in clinical practice].

  Dupliakov DV. Dupliakov DV. Kardiologiia. 2008;48(2):65-6. Kardiologiia. 2008. PMID: 18261011 Review. Russian. No abstract available.